UniDoc Provides Overview of Telehealth Sector Growth Opportunity

VANCOUVER, BC, — (January 19, 2022) – UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (“UniDoc,” or the “Company”), an innovator in the telehealth sector, is pleased to provide the following background information regarding its business model in relation to the growing sector opportunity.

UniDoc is a virtual telehealth solutions company. The Company’s primary offering under development has been branded as the Virtual Care Solutions Model (“VCSM”), a proprietary, customizable, and comprehensive telehealth solution that will integrate a range of physical enclosures, kiosks, and related configurable packaging with web-based services and analytical tools, along with access to the Company’s developing network of healthcare providers, pharmacies, and hospitals. The VCSM will include virtual/telehealth remote accessibility designed to provide patients with a live virtual visit with a doctor or other health professional in a controlled environment. The units will contain a selection of fully integrated diagnostic tools and are being designed to operate in locations such as pharmacies, community centres or care facilities through dedicated partnerships to be established with UniDoc. Additional diagnostic/interactive products and solutions are being purposed for the provisioning of health consultations from home or remote work environments.

According to the American Academy of Family Physicians, telemedicine refers specifically to remote clinical services, while telehealth can refer to remote non-clinical services. Therefore, we believe telehealth offers significant advantages and a wider range of available services including preventative, diagnostic and treatment services, offered remotely to patients using audio, video and other information and communications technology. Integrated telehealth solutions as envisioned by UniDoc, opens the door to a large segment of the population challenged by access, experience, or limited understanding of online computer technology. It is the Company’s belief that broadly deployed physical accessibility in controlled environments is the key to its business proposition.

In recent years, interest in the sector increased significantly, driven largely by challenges surrounding timely access to healthcare and the rise of consumer/patient demand. This increased interest in telehealth has sparked a period of significant overall growth of the sector.

  • According to industry research, the telehealth market was expected to grow to grow at a CAGR of 37.7% during the forecast period, to reach USD 191.7 billion by 2025 from an estimated USD 38.7 billion in 2020. (Telehealth/Telemedicine Market, November 2020, MarketsandMarkets).
  • Recent data showed telehealth utilization had stabilized at levels 38 times higher then before the pandemic (McKinsey & Co. July 9, 2021).
  • 57% of providers view telehealth more favourably than before COVID-19 and 64% are more comfortable with its use (McKinsey & Co. July 9, 2021).
  • Survey respondents indicate that between 40% and 60% of consumers want a broader set of virtual care solutions, such as a “digital front door” or lower-cost virtual health plan. (McKinsey & Co. July 9, 2021).
  • Forbes (Jan 6, 2022) states “Pandemic or not, the value of convenient and accessible virtual care has been realized.”
  • One-third of millennials and 41% of Generation Z prefer digital encounters with physicians over in-person visits. And with roughly half of employees using virtual health services in 2020 — up from 17% in 2019 — there’s still a lot of room to grow. (Forbes, Jan 6, 2022).

The COVID-19 pandemic has driven significant growth in adoption of technology in the North American healthcare industry. As the virus spread, healthcare systems have been forced to adapt traditional ways of providing healthcare, quickly changing the utilization of telehealth services. Providers that had already invested in virtual care solutions prior to COVID-19 were forced to test scalability of these solutions, and those that did not invest in such a solution were pushed to identify and leverage technology for the first time, thus driving the growth of new collaborations and the creation of significant market opportunities.

The October 2020 Gartner Market Guide for Virtual Care Solutions highlighted the trend of increased reliance on technologies, noting that by 2022 in North America 30% of all ambulatory encounters were predicted to be virtual, up from about 2% at the start of 2020, and further indicated that the structural changes are here to stay.

In this context, the Company believes that the ability to support the delivery of virtual care is now a viable and sustainable growth opportunity for innovative professional healthcare delivery organizations such as UniDoc. We believe virtual care has the power to reduce economic strain on the public system, improve treatment for those suffering from health-related challenges, and empower individuals to become more engaged in their health.

North America is still in the early stages of telehealth/telemedicine services, and trend data (Graphical Research, Feb 3, 2021) suggests the domestic digital health space continues to lag behind other developed countries. Telemedicine was initially developed to bring health services closer to remote populations with limited health resources. Later, it became a means to improve the quality of medical care by facilitating training and decision making of health care professionals in remote areas. Today, UniDoc is preparing a solution to offer broad nationwide access predicated on improving patient experiences by shortening timelines and delivering better outcomes.

We encourage engagement, questions, and interest, so please stay in touch and invite anyone who might be interested in our story to visit our brand-new website at www.unidoctor.com and signup to receive the latest information with updates on our activities, events and progress. You are also invited to join us on social media with Facebook, Twitter or Instagram.

On Behalf of The Board of Directors,

Sincerely,

~Antonio Baldassarre~

Antonio Baldassarre
CEO, President & Director

UniDoc Health Corp. (CSE: UDOC)As part of the Company’s disclosure obligations as a public issuer, ongoing financial and material filings can be found under the Company’s profile on the System for Electronic Document Analysis and Retrieval (SEDAR) at www.sedar.com.

About UniDoc Health Corp. (CSE: UDOC) (FRA: L7T)

UniDoc is developing a telehealth solution which is being designed as a self-contained remote virtual clinic within a private kiosk for patients to undergo full consultations as if they were present in a physician’s office. Telehealth opens the doors to a large segment of the population challenged by access, experience or understanding of online computer technology. It is the Company’s belief that physical accessibility is the key to its business proposition. UniDoc is dedicated to unlocking shareholder value by delivering an excellent product and sophisticated commercial network within an expedited timeframe. Find out more at: https://unidoctor.com and connect with our social media on Facebook, Twitter or Instagram.

For further information, please contact

UniDoc Investor Relations
Tel: +1 778.383.6731
Email: info@unidoctor.com

Austin Thornberry, Director
Tel: +1 647.463.8689
Email: austin@unidoctor.com

Media Inquiries
media@unidoctor.com

Forward-Looking Statement

This news release contains statements and information that, to the extent that they are not historical fact, may constitute “forward-looking information” within the meaning of applicable securities legislation. Forward-looking information may include financial and other projections, as well as statements regarding future plans, objectives, or economic performance, or the assumption underlying any of the foregoing. In some cases, forward-looking statements can be identified by terms such as “may”, “would”, “could”, “will”, “likely”, “except”, “anticipate”, “believe”, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook”, or the negative thereof or other similar expressions concerning matters that are not historical facts. Examples of such statements include, but are not limited to, statements with respect to the Company’s primary product offering and features thereof, the Company’s commercialization of its telehealth platform, partnerships to be established by the Company, and the projected growth of the telehealth industry.

Forward-looking information is based on the assumptions, estimates, analysis, and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. The material factors and assumptions used to develop the forward-looking information contained in this news release include, but are not limited to, key personnel and qualified employees continuing their involvement with the Company; the Company’s ability to secure additional financing on reasonable terms; the competitive conditions of the industries in which the Company operates; and laws and any amendments thereto applicable to the Company.

Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, without limitation,  risks relating to the future business plans of the Company; risks that the Company will not be able to retain its key personnel; risks that the Company will not be able to secure financing on reasonable terms or at all, as well as all of the other risks as described in the Company’s  final prospectus dated December 2, 2021 under the heading “Risks Factors.” Accordingly, readers should not place undue reliance on any such forward-looking information. Further, any forward-looking information speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The Company does not undertake any obligation to update any forward-looking information to reflect information or events after the date on which it is made or to reflect the occurrence of unanticipated events, except as required by law, including securities laws.

The CSE does not accept responsibility for the adequacy or accuracy of this release.

Sign Up For News Alerts

Enter your details below and we will add you to our News Alerts list.

Consent(Required)

Austin Thornberry

Director

Mr. Thornberry is a seasoned finance professional with a background in advising start-up companies in the venture capital market. He brings extensive experience working with high-growth companies across numerous industries through his past work in the technology and innovation banking group at the Bank of Montreal and in the financial services arm of Ernst & Young advising on multiple capital markets transactions. He obtained his bachelor of commerce at McGill University and has held the CPA, CA, designation since 2019.

Matt Chatterton

DIRECTOR

Mr. Chatterton brings over 15 years of experience in development and execution of complex projects. His expertise includes project management, facility management, logistics, supply side processes and procedures at several operations in Canada and internationally. He has been involved in the public markets for the last three years managing initial public offering processes and transitioning businesses to postlisting operations. Mr. Chatterton is a professional engineer and graduate of Canada’s Queens University with a master’s degree in chemical process engineering (2003).

Sina Pirooz

Director

Mr. Pirooz is a registered and practicing pharmacist, and has been a professional member of the College of Pharmacists of British Columbia since 2003, with over 20 years of pharmaceuticals and pharmacy management experience. As owner of a compounding pharmacy, Mr. Pirooz has been dispensing pharmaceuticals for over 18 years and provides pharmacist and pharmacy management services to many of Canada’s largest pharmacy chains and drug stores. Mr. Pirooz is also the CEO and a director of Genix Pharmaceuticals Corporation, a company listed for trading on the TSXV.

Dr. Sazzad Hossain, PhD

Chief Scientific Officer

He is the former Chief Scientific Officer of InMed Pharmaceuticals Inc., a leading public Canadian bio-pharmaceutical company. Previously he worked as Senior Scientist at Biotechnology Research Institute of National Research Council Canada. Working with the Canadian government he helped establish the pharmacology laboratory to evaluate safety and efficacy of cannabinoid-based and other drugs under development for cancer, cardiovascular and ocular diseases.

Jacob Moshinsky

Chief Operating Officer

Jacob is the CEO & founder of MoviWear a GPS, fall down detection & remote vital-sign monitoring platform, alerting caregivers of real-time emergencies. Jacob is a communications and technology expert with over 15 years’ experience in the field. the NurtureWatch health monitoring Smartwatch and MoviWearMED remote vital sign monitoring platform Prior to MoviWear, Jacob worked in both the Canadian telecom and the CPG industry. He led the Product Development and Business Strategy team at TELUS for the Small Business Portfolio. Jacob also worked in various product and service management roles within Rogers Communications where he launched and managed wireless and wireline products.

Antonio Baldassarre

CEO, President and Director

Mr. Baldassarre has held senior management and director positions of new business start-ups and established multinational organizations with over 30 years of experience in the Security, Information Technology and Communications industries. With leadership skills in management of international operations, shareholder exit strategies, and overall business development, he has utilized a wide range of strategic programs to maximize organic growth into specific industry segments through OEM, alliances, and direct multi-level distribution channels. Mr. Baldassarre is able to plan, organize and direct all aspects of a Corporation from Operations, P&L oversight, product distribution, Product promotions, sales and development activities and initiatives utilizing my extensive marketing/sales senior management experience with developed abilities in team leadership and program/campaign development. Directly involved in the growth, branding and ultimately optimizing market share, product awareness, revenues, profitability and shareholder value. Mr. Baldassare is also the President of LRG Security Canada Inc. and LRG Security Europe.

Franco Staino

Chairman of the Board of Directors

Mr. Franco Staino is the Developer of the Italian National anti-counterfeiting Program for Pharmaceuticals developed in conjunction with the Ministry of Health as well as the National Certification Program for all unsold Prescription Drugs in Partnership with Pharmindustria (National association of all Pharmaceutical Manufactures) through ASSINDE.

Through one of his Companies, Carlucci are responsible for the control, labelling and collection of all pharmaceutical prescription drugs in Italy, under the PHG umbrella Franco opened first a UK division, now has also expanded into 4 African countries. Over the Years Franco has been a Board Member and Contributor on various International Committees, including the United Nations.